Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitroreductase-1 is a member of the nitroreductase family of enzymes that catalyze the reduction of nitro-containing compounds, particularly nitroaromatics. It is a flavoprotein that utilizes flavin mononucleotide (FMN) as a cofactor and typically functions as a homodimer. Nitroreductase-1 plays roles in bacterial metabolism and is used in cancer gene therapy to convert non-toxic prodrugs into cytotoxic agents under hypoxic conditions typical of tumor microenvironments. It shows broad substrate specificity and operates via a ping-pong bi-bi mechanism.
Catalyzes two-electron reductions of nitroaromatic compounds to their corresponding nitroso derivatives and further to hydroxylamines, utilizing NADH or NADPH as electron donors. Operates via a ping-pong bi-bi mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitroreductase-1 (NTR1).